Trajectories of Drug Use and Mortality Outcomes Among Adults Followed Over 18 Years
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
For adults in general population community settings, data regarding long-term course and outcomes of illicit drug use are sparse, limiting the formulation of evidence-based recommendations for drug use screening of adults in primary care.
To describe trajectories of three illicit drugs (cocaine, opioids, amphetamines) among adults in community settings, and to assess their relation to all-cause mortality.
Longitudinal cohort, 1987/88 – 2005/06.
Community-based recruitment from four cities (Birmingham, Chicago, Oakland, Minneapolis).
Healthy adults, balanced for race (black and white) and gender were assessed for drug use from 1987/88—2005/06, and for mortality through 12/31/2008 (n = 4301)
Use of cocaine, amphetamines, and opioids (last 30 days) was queried in the following years: 1987/88, 1990/91, 1992/93, 1995/96, 2000/01, 2005/06. Survey-based assessment of demographics and psychosocial characteristics. Mortality over 18 years.
Trajectory analysis identified four groups: Nonusers (n = 3691, 85.8%), Early Occasional Users (n = 340, 7.9%), Persistent Occasional Users (n = 160, 3.7%), and Early Frequent/Later Occasional Users (n = 110, 2.6%). Trajectories conformed to expected patterns regarding demographics, other substance use, family background and education. Adjusting for demographics, baseline health status, health behaviors (alcohol, tobacco), and psychosocial characteristics, Early Frequent/Later Occasional Users had greater all-cause mortality (Hazard Ratio, HR = 4.94, 95% CI = 1.58–15.51, p = 0.006).
Study is restricted to three common drugs, and trajectory analyses represent statistical approximations rather than identifiable “types”. Causal inferences are tentative.
Four trajectories describe illicit drug use from young adulthood to middle age. Two trajectories, representing over one third of adult users, continued use into middle age. These persons were more likely to continue harmful risk behaviors such as smoking, and more likely to die.
- Chen K, Kandel DB. The natural history of drug use from adolescence to the mid-thirties in a general population sample. Am J Public Health. 1995;85(1):41–7. CrossRef
- Bachman JG, O’Malley PM, Schulenberg JE, Johnston LD, Bryant AL, Merline AC. The decline of substance use in young adulthood: changes in social activities, roles, and beliefs. Mahwah: Erlbaum; 2002.
- Office of Applied Studies SAaMHSA. Results from the 2009 National Survey on Drug Use and Health: detailed tables. Rockville, MD; 2010.
- Substance Abuse and Mental Health Services Administration, Office of Applied Studies. An examination of trends in illicit drug use among adults aged 50 to 59 in the United States. Rockville: OAS Data Review; 2009.
- Colliver JD, Compton WM, Gfroerer JC, Condon T. Projecting drug use among aging baby boomers in 2020. Ann Epidemiol. 2006;16(4):257–65. CrossRef
- U.S. Preventive Services Task Force. Screening for illicit drug Use: U.S. preventive services task force recommendation statement. Rockville: Agency for Healthcare Research and Quality; 2008.
- Andreasson S, Allebeck P. Cannabis and mortality among young men: a longitudinal study of Swedish conscripts. Scan J Soc Med. 1990;18(1):9–15.
- Friedman GD, Cutter GR, Donahue RP, et al. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol. 1988;41(11):1105–16. CrossRef
- Nagin DS, Odgers CL. Group-based trajectory modeling in clinical research. Annu Rev Clin Psychol. 2010;6:109–38. CrossRef
- Golub A, Johnson BD. Variation in youthful risks of progression from alcohol and tobacco to marijuana and to hard drugs across generations. Am J Public Health. 2001;91(2):225–32. CrossRef
- Hser YI, Huang D, Brecht ML, Li L, Evans E. Contrasting trajectories of heroin, cocaine, and methamphetamine use. J Addict Dis. 2008;27(3):13–21. CrossRef
- Kertesz SG, Pletcher MJ, Safford M, et al. Illicit drug use in young adults and subsequent decline in general health: the coronary artery risk development in young adults (CARDIA) study. Drug Alcohol Depend. 2007;88(2–3):224–33. CrossRef
- Hughes GH, Cutter G, Donahue R, et al. Recruitment in the coronary artery disease risk development in young adults (CARDIA) study. Control Clin Trials. 1987;8(4 Suppl):68S–73. CrossRef
- Substance Abuse and Mental Health Services Administration, Office of Applied Studies. National household survey on drug abuse: public release codebook. Rockville: U.S. Department of Health and Human Services; 1985.
- Berkman LF, Syme SL. Social networks, host resistance, and mortality: a nine-year follow-up study of Alameda County residents. Am J Epidemiol. 1979;109(2):186–204.
- Knox SS, Siegmund KD, Weidner G, Ellison RC, Adelman A, Paton C. Hostility, social support, and coronary heart disease in the national heart, lung, and blood institute family heart study. Am J Cardiol. 1998;82(10):1192–6. CrossRef
- Spielberger CD. Manual for the State-Trait Anxiety Inventory (STAI). Palo Alto: Consulting Psychologists Press; 1983.
- Repetti RL, Taylor SE, Seeman TE. Risky families: family social environments and the mental and physical health of offspring. Psychol Bull. 2002;128(2):330–66. CrossRef
- Taylor SE, Lerner JS, Sage RM, Lehman BJ, Seeman TE. Early environment, emotions, responses to stress, and health. J Pers. 2004;72(6):1365–93. CrossRef
- Pletcher MJ, Hulley BJ, Houston T, Kiefe CI, Benowitz N, Sidney S. Menthol cigarettes, smoking cessation, atherosclerosis, and pulmonary function: the coronary artery risk development in young adults (CARDIA) study. Arch Intern Med. 2006;166(17):1915–22. CrossRef
- Pletcher MJ, Varosy P, Kiefe CI, Lewis CE, Sidney S, Hulley SB. Alcohol consumption, binge drinking, and early coronary calcification: findings from the coronary artery risk development in young adults (CARDIA) study. Am J Epidemiol. 2005;161(5):423–33. CrossRef
- Goldberg D. World Health Organization Guide to Mental Health in Primary Care. London: WHO Collaborating Centre for Research and Training for Mental Health; 2000.
- Saitz R. Unhealthy alcohol use. N Engl J Med. 2005;352(6):596–607. CrossRef
- Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psych Meas. 1977;1:385–401. CrossRef
- Iribarren C, Jacobs DR, Kiefe CI, et al. Causes and demographic, medical, lifestyle and psychosocial predictors of premature mortality: the CARDIA study. Soc Sci Med. 2005;60(3):471–82. CrossRef
- Nagin DS. Group-based modeling of development. Cambridge: Harvard University Press; 2005.
- Elder GH Jr. The life course as developmental theory. Child Dev. 1998;69(1):1–12.
- Szklo M. Population-based cohort studies. Epidemiol Rev. 1998;20(1):81–90. CrossRef
- Jones BL, Nagin DS. Advances in group-based trajectory modeling and an SAS procedure for estimating them. Sociol Methods Res. 2007;35(4):542–71. CrossRef
- Schulenberg JE, Merline AC, Johnston LD, O’Malley PM, Bachman JG, Laetz VB. Trajectories of marijuana use during the transition to adulthood: the big picture based on national panel data. J Drug Issues. 2005;35(2):255–79. CrossRef
- Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Substance Use among Black Adults. Rockville, MD; 2010.
- Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.[see comment]. Arch Gen Psychiatry. 2005;62(6):617–27. CrossRef
- Falck RS, Wang J, Carlson RG. Crack cocaine trajectories among users in a midwestern American city. Addiction. 2007;102(9):1421–31. CrossRef
- Office of Applied Studies. 1998 National Household Survey on Drug Abuse: Summary Tables. Prevalence Estimates, standard errors, and p-values (Vols. 1& 2). Substance Abuse and Mental Health Services Administration; 1999.
- United States Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies. National Survey on Drug Use and Health. 2009-12-16 ed. Ann Arbor, MI: Inter-University Consortium for Political and Social Research [distributor]; 2009 [Computer file].
- Hall BH, Mairesse J, Turner L. Identifying age, cohort and period effects in scientific research productivity: discussion and illustration using simulated and actual data on French physicists. Econ Innov New Technol. 2007;15(4–5):391–413.
- Nagin DS. Analyzing developmental trajectories: a semiparametric group-based approach. Psychol Meth. 1999;4(2):139–57. CrossRef
- United States Preventive Services Task Force. Screening for illicit drug use topic page. Rockville: Agency for Healthcare Research and Quality; 2008.
- World Health Organization. The alcohol, smoking and substance involvement screening test (ASSIST): development, reliability and feasibility. Addiction. 2002;97(9):1183–94. CrossRef
- Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R. A single-question screening test for drug use in primary care. Arch Intern Med. 2010;170(13):1155–60. CrossRef
- Trajectories of Drug Use and Mortality Outcomes Among Adults Followed Over 18 Years
Journal of General Internal Medicine
Volume 27, Issue 7 , pp 808-816
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- longitudinal data
- Industry Sectors
- Author Affiliations
- 1. Center for Surgical Medical and Acute Care Research at the Birmingham VA Medical Center, Birmingham, AL, USA
- 2. Division of Preventive Medicine, University of Alabama at Birmingham School of Medicine, 1530 3rd Ave South, MT608, Birmingham, AL, 35294, USA
- 3. Department of Health Behavior, University of Alabama at Birmingham School of Public Health, 1665 University Blvd. 227 RPHB, Birmingham, AL, 35294, USA
- 6. Department of Surgery, University of Alabama at Birmingham School of Medicine, 1530 3rd Ave South, MT608, Birmingham, AL, 35294, USA
- 4. Department of Statistics, Carnegie Mellon University, 5000 Forbes Avenue, Pittsburgh, PA, 15213, USA
- 5. Department of Epidemiology and Biostatistics, University of California at San Francisco, 1701 Divisadero Street, San Francisco, CA, 94115, USA